Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1D | P25100 | 1/20 | 0.55 |
| ▸ | PTAFR | P25105 | 1/20 | 0.55 |
| ▸ | HTR1D | P28221 | 1/20 | 0.55 |
| ▸ | HTR2C | P28335 | 1/20 | 0.55 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.55 |
| ▸ | DRD3 | P35462 | 1/20 | 0.55 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.53 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | GMNN | O75496 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | BLM | P54132 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.49 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.49 |
| ▸ | PRKCG | P05129 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3655243 | 0.96 | ADRA1D (0.61) | ADRA1DPTAFRHTR1DHTR2CADRA1B | |
| SCHEMBL1260833 | 0.85 | ADRA1D (0.61) | ADRA1DPTAFRHTR1DHTR2CADRA1B | |
| SCHEMBL1260814 | 0.83 | ADRA1D (0.57) | ADRA1DPTAFRHTR1DHTR2CADRA1B | |
| SCHEMBL1260662 | 0.83 | ADRA1D (0.57) | ADRA1DPTAFRHTR1DHTR2CADRA1B | |
| SCHEMBL368310 | 0.81 | LMNA (0.56) | ADRA1DPTAFRHTR1DHTR2CADRA1B | |
| SCHEMBL6235107 | 0.78 | TSHR (0.54) | LMNAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL9067446 | 0.78 | ADRA1D (0.62) | ADRA1DPTAFRHTR1DHTR2CADRA1B | |
| SCHEMBL14990456 | 0.77 | LMNA (0.64) | ADRA1DPTAFRHTR1DHTR2CADRA1B | |
| SCHEMBL3923049 | 0.77 | LMNA (0.64) | ADRA1DPTAFRHTR1DHTR2CADRA1B | |
| SCHEMBL423161 | 0.77 | LMNA (0.57) | ADRA1DPTAFRHTR1DHTR2CADRA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130034509-A1 | COSMETIC TREATMENT METHOD INVOLVING A COMPOUND CAPABLE OF CONDENSING IN SITU | L'OREAL (FR) | 2013-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130034509-A1 | COSMETIC TREATMENT METHOD INVOLVING A COMPOUND CAPABLE OF CONDENSING IN SITU | POLR1C, CUTA, MITF | ADRA1D 4768/4885PTAFR 4388/4885HTR1D 4188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.